Our science development strategies are driven by the recent advances in basic neurobiology, neurodegeneration, and neuroinflammation, and on our understanding of the pathogenesis of brain diseases whether at the genetic, molecular, cellular and system level. This scientific knowledge helps us to select relevant targets, and to search for drugs that act through them to combat the neurological disease.